152 related articles for article (PubMed ID: 18460899)
1. Curcumin alleviates dystrophic muscle pathology in mdx mice.
Pan Y; Chen C; Shen Y; Zhu CH; Wang G; Wang XC; Chen HQ; Zhu MS
Mol Cells; 2008 Jun; 25(4):531-7. PubMed ID: 18460899
[TBL] [Abstract][Full Text] [Related]
2. Imatinib attenuates skeletal muscle dystrophy in mdx mice.
Huang P; Zhao XS; Fields M; Ransohoff RM; Zhou L
FASEB J; 2009 Aug; 23(8):2539-48. PubMed ID: 19289603
[TBL] [Abstract][Full Text] [Related]
3. Increased resting intracellular calcium modulates NF-κB-dependent inducible nitric-oxide synthase gene expression in dystrophic mdx skeletal myotubes.
Altamirano F; López JR; Henríquez C; Molinski T; Allen PD; Jaimovich E
J Biol Chem; 2012 Jun; 287(25):20876-87. PubMed ID: 22549782
[TBL] [Abstract][Full Text] [Related]
4. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.
Messina S; Bitto A; Aguennouz M; Vita GL; Polito F; Irrera N; Altavilla D; Marini H; Migliorato A; Squadrito F; Vita G
Neuromuscul Disord; 2011 Aug; 21(8):579-89. PubMed ID: 21658942
[TBL] [Abstract][Full Text] [Related]
5. Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice.
Durham WJ; Arbogast S; Gerken E; Li YP; Reid MB
Muscle Nerve; 2006 Sep; 34(3):298-303. PubMed ID: 16718687
[TBL] [Abstract][Full Text] [Related]
6. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
8. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
Radley HG; Davies MJ; Grounds MD
Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
[TBL] [Abstract][Full Text] [Related]
9. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice.
Altamirano F; Valladares D; Henríquez-Olguín C; Casas M; López JR; Allen PD; Jaimovich E
PLoS One; 2013; 8(12):e81222. PubMed ID: 24349043
[TBL] [Abstract][Full Text] [Related]
11. Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice.
Altamirano F; Perez CF; Liu M; Widrick J; Barton ER; Allen PD; Adams JA; Lopez JR
PLoS One; 2014; 9(9):e106590. PubMed ID: 25181488
[TBL] [Abstract][Full Text] [Related]
12. Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function.
Ermolova NV; Martinez L; Vetrone SA; Jordan MC; Roos KP; Sweeney HL; Spencer MJ
Neuromuscul Disord; 2014 Jul; 24(7):583-95. PubMed ID: 24844454
[TBL] [Abstract][Full Text] [Related]
13. L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers.
Hnia K; Gayraud J; Hugon G; Ramonatxo M; De La Porte S; Matecki S; Mornet D
Am J Pathol; 2008 Jun; 172(6):1509-19. PubMed ID: 18458097
[TBL] [Abstract][Full Text] [Related]
14. Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.
Reay DP; Yang M; Watchko JF; Daood M; O'Day TL; Rehman KK; Guttridge DC; Robbins PD; Clemens PR
Neurobiol Dis; 2011 Sep; 43(3):598-608. PubMed ID: 21624467
[TBL] [Abstract][Full Text] [Related]
15. Reduction of Oxidative Damage and Inflammatory Response in the Diaphragm Muscle of mdx Mice Using Iron Chelator Deferoxamine.
Moraes LH; de Burgos RR; Macedo AB; de Almeida Hermes T; de Faria FM; Minatel E
Biol Trace Elem Res; 2015 Sep; 167(1):115-20. PubMed ID: 25762099
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
18. Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies.
Sanarica F; Mantuano P; Conte E; Cozzoli A; Capogrosso RF; Giustino A; Cutrignelli A; Cappellari O; Rolland JF; De Bellis M; Denora N; Camerino GM; De Luca A
Pharmacol Res; 2019 Jul; 145():104260. PubMed ID: 31059789
[TBL] [Abstract][Full Text] [Related]
19. Fish oil attenuated dystrophic muscle markers of inflammation via FFA1 and FFA4 in the mdx mouse model of DMD.
Maciel Junior M; Camaçari de Carvalho S; Saenz Suarez PA; Santo Neto H; Marques MJ
Anat Rec (Hoboken); 2021 Jun; 304(6):1305-1312. PubMed ID: 33136305
[TBL] [Abstract][Full Text] [Related]
20. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.
Messina S; Altavilla D; Aguennouz M; Seminara P; Minutoli L; Monici MC; Bitto A; Mazzeo A; Marini H; Squadrito F; Vita G
Am J Pathol; 2006 Mar; 168(3):918-26. PubMed ID: 16507907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
